| Issuer | % of Class | Filed |
|---|---|---|
|
Connect Biopharma Holdings Ltd
13G/A
Amendment 6
CNTB · 207523101
|
4.0% |
8/14/2026
Event 6/30/2026
|
|
Connect Biopharma Holdings Ltd
13G/A
Amendment 5
CNTB · 207523101
|
6.2% |
5/15/2026
Event 3/31/2026
|
|
Connect Biopharma Holdings Ltd
13G/A
Amendment 4
CNTB · 207523101
|
9.0% |
2/17/2026
Event 12/31/2025
|
|
Connect Biopharma Holdings Ltd
13G/A
Amendment 3
CNTB · 207523101
|
9.9% |
11/28/2025
Event 11/26/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.